312 related articles for article (PubMed ID: 8820954)
1. High-dose chemotherapy with autologous stem cell rescue for breast cancer: yesterday, today and tomorrow.
Brockstein BE; Williams SF
Stem Cells; 1996 Jan; 14(1):79-89. PubMed ID: 8820954
[TBL] [Abstract][Full Text] [Related]
2. A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer.
Elias AD; Richardson P; Avigan D; Ibrahim J; Joyce R; Demetri G; Levine J; Warren D; Arthur T; Reich E; Wheele C; Frei E; Ayash L
Bone Marrow Transplant; 2001 Feb; 27(3):269-78. PubMed ID: 11277174
[TBL] [Abstract][Full Text] [Related]
3. [Significance of stem cell-supported high-dose chemotherapy in the treatment of gynecological malignancies: indications and current clinical trials in the Federal Republic of Germany].
Nitz U; Frick M; Adomeit A; Jackisch C; Schwenkhagen A; Möbus V; Bender HG
Zentralbl Gynakol; 1997; 119(5):195-203. PubMed ID: 9281252
[TBL] [Abstract][Full Text] [Related]
4. [Studies with high-dose chemotherapy and subsequent autologous stem cell transplantation in breast carcinoma].
Nitz U; Adomeit A; Mohrmann S; Fossari A; Frick M
Praxis (Bern 1994); 1998 Apr; 87(17):578-83. PubMed ID: 9623324
[TBL] [Abstract][Full Text] [Related]
5. High-dose chemotherapy of breast cancer.
Crown J; Raptis G; Hamilton N; Hudis C; Vahclat L; Fennelly D; Norton L
Can J Oncol; 1995 Dec; 5 Suppl 1():80-2. PubMed ID: 8853530
[TBL] [Abstract][Full Text] [Related]
6. High-dose chemotherapy in breast cancer -- the perils of history uncontrolled.
Miller KD; Sledge GW
Medscape Womens Health; 2000; 5(3):E1. PubMed ID: 11109042
[TBL] [Abstract][Full Text] [Related]
7. [High dose chemotherapy in treatment of breast carcinoma: current status and limits of this method of therapy].
Derigs HG; Huber C; Mahlke M; Kolbe K
Geburtshilfe Frauenheilkd; 1996 Apr; 56(4):190-7. PubMed ID: 8682284
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer: High-Dose Therapy.
Subramanyan S; Kennedy MJ
Oncologist; 1998; 3(5):289-299. PubMed ID: 10388119
[TBL] [Abstract][Full Text] [Related]
9. Cardiac sequelae of doxorubicin and paclitaxel as induction chemotherapy prior to high-dose chemotherapy and peripheral blood progenitor cell transplantation in women with high-risk primary or metastatic breast cancer.
Klein JL; Rey PM; Dansey RD; Karanes C; Du W; Abella E; Cassells L; Hamm C; Peters WP; Baynes RD
Bone Marrow Transplant; 2000 May; 25(10):1047-52. PubMed ID: 10828864
[TBL] [Abstract][Full Text] [Related]
10. [Combination of high-dose chemotherapy with autologous hematopoietic stem cell transplantation for recurrent and high-risk breast cancer: a pilot study].
Shi Y; Pan F; Han X
Zhonghua Yi Xue Za Zhi; 1999 Dec; 79(12):890-3. PubMed ID: 11715500
[TBL] [Abstract][Full Text] [Related]
11. Complete response after high-dose chemotherapy and autologous hemopoietic stem cell transplatation in metastatic breast cancer results in survival benefit.
Kurian S; Qazilbash M; Fay J; Wolff S; Herzig R; Hobbs G; Bunner P; Weisenborn R; Aya-Ay M; Lynch J; Ericson S
Breast J; 2006; 12(6):531-5. PubMed ID: 17238982
[TBL] [Abstract][Full Text] [Related]
12. High-dose chemotherapy consolidation with autologous stem cell rescue in metastatic breast cancer: a 10-year experience.
Laport GF; Grad G; Grinblatt DL; Bitran JD; Williams SF
Bone Marrow Transplant; 1998 Jan; 21(2):127-32. PubMed ID: 9489628
[TBL] [Abstract][Full Text] [Related]
13. [High dosage chemotherapy and peripheral blood stem cell transplantation in breast carcinoma].
Jentsch-Ullrich K; Höffken HG; Franke A
Zentralbl Chir; 1998; 123 Suppl 5():162-4. PubMed ID: 10063605
[TBL] [Abstract][Full Text] [Related]
14. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
15. Dose-intense paclitaxel, etoposide and cyclophosphamide: a safe and active regimen for tumor cytoreduction and stem cell mobilization in metastatic breast cancer.
Bilgrami S; Feingold JM; Bona RD; Edwards RL; Khan AM; Rodriguez-Pinero F; Khan IA; Kazierad D; Clive J; Tutschka PJ
Bone Marrow Transplant; 2000 Jan; 25(2):123-30. PubMed ID: 10673668
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle.
Bashey A; Corringham S; Garrett J; Lane TA; Gilpin EA; Corringham RE; Law P; Ho AD
Bone Marrow Transplant; 2000 Mar; 25(5):519-24. PubMed ID: 10713629
[TBL] [Abstract][Full Text] [Related]
17. [Autologous hematopoietic stem cell transplantation for the treatment of breast cancer].
Mukaiyama T; Okamoto R; Sasaki T
Gan To Kagaku Ryoho; 1995 Oct; 22(12):1731-40. PubMed ID: 7574803
[TBL] [Abstract][Full Text] [Related]
18. Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer.
Biron P; Durand M; Roché H; Delozier T; Battista C; Fargeot P; Spaeth D; Bachelot T; Poiget E; Monnot F; Tanguy ML; Curé H
Bone Marrow Transplant; 2008 Mar; 41(6):555-62. PubMed ID: 18037940
[TBL] [Abstract][Full Text] [Related]
19. Systemic therapy of inflammatory breast cancer from high-dose chemotherapy to targeted therapies: the French experience.
Viens P; Tarpin C; Roche H; Bertucci F
Cancer; 2010 Jun; 116(11 Suppl):2829-36. PubMed ID: 20503415
[TBL] [Abstract][Full Text] [Related]
20. [Chemotherapy with autologous stem cell support for breast cancer].
Tajima T; Tokuda Y; Okumura T; Kubota M; Mitomi T
Gan To Kagaku Ryoho; 1994 Jun; 21 Suppl 2():255-8. PubMed ID: 7913601
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]